TUESDAY, NOVEMBER 21, 2017

Polio immunization campaign begins in Iraq

Polio Read More »

University of Maryland researcher leads charge in development of Ebola vaccine

A researcher at the University of Maryland's (UM) School of Medicine is currently working to develop a vaccine against the Ebola virus, which has claimed more than 1,000 lives in West Africa. Read More »

Dozens of companies to ship supplies to areas stricken by Ebola outbreak

Ebola Read More »

MRSA Survivors Network calls for political action

MRSA Read More »

Idaho public health officials urge residents to vaccinate against whooping cough

Pertussis Read More »

Sanofi, PATH begin shipments of new malaria treatment

Sanofi and PATH announced on Tuesday that the first large-scale shipments of an antimalarial treatment using a semisynthetic artemisinin derivative were shipped to malaria-endemic countries in Africa. Read More »

New HIV therapy shows promise in eliminating latent virus from cells

HIV Read More »

More than 50 CDC staff fighting ebola in West Africa

The Centers for Disease Control and Prevention said on Wednesday that it now has more than 50 experts in West Africa to battle the ongoing ebola virus outbreak there. Read More »

Researchers discover genetic trigger that could lead to new autoimmune, cancer treatments

DNA helix Read More »

Study finds Fluzone High-Dose more effective in older adults than standard vaccine

Sanofi Pasteur announced on Wednesday that the New England Journal of Medicine published results that showed Fluzone High-Dose was more effective in preventing influenza in adults aged 65 years and older than Fluzone. Read More »

WHO, travel sector put together task force to monitor Ebola threat in transportation

The World Health Organization and groups from the travel and tourism sector recently assembled a task force to monitor efforts by transportation authorities to contain the spread of the Ebola virus. Read More »

Study shows effectiveness of experimental chikungunya vaccine

chikungunya virus Read More »

Thomson Reuters' ISP & Science division releases disease profile on Ebola

Thomson Reuters' Intellectual Property and Science division recently released a comprehensive disease profile on the Ebola virus that details new treatments and experimental drugs nearing development. Read More »

FDA accepts Pfizer's meningococcal vaccine license application

Pfizer, Inc., announced on Friday that the U.S. Food and Drug Administration accepted the company's Biological License Application for its meningococcal disease vaccine candidate for review. Read More »

WHO calls on international community to support health preventative efforts in Ukraine

The World Health Organization (WHO) called on the international community on Tuesday-World Humanitarian Day-to pledge $14 million to help protect the health of populations affected by the conflict in Ukraine. Read More »

ITS, WCCT Global reach influenza strain purchase agreement

Influenza Read More »

Flublok vaccine to be available at more than 230 Passport Health locations nationwide

Protein Sciences Corp. and Passport Health announced on Tuesday that the Flublok vaccine will be available this fall at all of Passport Health's locations across the U.S. Read More »

EU reports first 2014 West Nile virus case

The European Centre for Disease Prevention and Control (ECDC) announced on Friday that the first case of West Nile fever of the 2014 transmission season was reported in the European Union last week. Read More »

Zostavax shingles vaccine available on Danish market

shingles Read More »

Novan Therapeutics announces positive results of nitric oxide studies

Clinical-stage biotech company Novan Therapeutics announced on Thursday that two studies showed its Nitricil platform technology is efficacious against most multi-drug resistant pathogens. Read More »